Logo image of NRC

NATIONAL RESEARCH CORP (NRC) Stock Fundamental Analysis

NASDAQ:NRC - Nasdaq - US6373722023 - Common Stock - Currency: USD

11.87  +1.03 (+9.5%)

After market: 11.87 0 (0%)

Fundamental Rating

5

NRC gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. While NRC belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. NRC is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year NRC was profitable.
In the past year NRC had a positive cash flow from operations.
In the past 5 years NRC has always been profitable.
In the past 5 years NRC always reported a positive cash flow from operatings.
NRC Yearly Net Income VS EBIT VS OCF VS FCFNRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

1.2 Ratios

Looking at the Return On Assets, with a value of 18.70%, NRC belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
NRC has a better Return On Equity (79.21%) than 98.04% of its industry peers.
With an excellent Return On Invested Capital value of 28.29%, NRC belongs to the best of the industry, outperforming 98.04% of the companies in the same industry.
NRC had an Average Return On Invested Capital over the past 3 years of 37.15%. This is significantly above the industry average of 9.13%.
The 3 year average ROIC (37.15%) for NRC is well above the current ROIC(28.29%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 18.7%
ROE 79.21%
ROIC 28.29%
ROA(3y)22.78%
ROA(5y)24%
ROE(3y)62.21%
ROE(5y)57.67%
ROIC(3y)37.15%
ROIC(5y)35.26%
NRC Yearly ROA, ROE, ROICNRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50 100 150

1.3 Margins

NRC's Profit Margin of 17.32% is amongst the best of the industry. NRC outperforms 98.04% of its industry peers.
NRC's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 24.94%, NRC belongs to the best of the industry, outperforming 97.06% of the companies in the same industry.
In the last couple of years the Operating Margin of NRC has declined.
NRC's Gross Margin of 60.20% is amongst the best of the industry. NRC outperforms 81.37% of its industry peers.
NRC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 24.94%
PM (TTM) 17.32%
GM 60.2%
OM growth 3Y-10.18%
OM growth 5Y-5.95%
PM growth 3Y-11.83%
PM growth 5Y-7.25%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
NRC Yearly Profit, Operating, Gross MarginsNRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

4

2. Health

2.1 Basic Checks

NRC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for NRC has been reduced compared to 1 year ago.
NRC has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, NRC has a worse debt to assets ratio.
NRC Yearly Shares OutstandingNRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
NRC Yearly Total Debt VS Total AssetsNRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

NRC has an Altman-Z score of 3.10. This indicates that NRC is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of NRC (3.10) is better than 68.63% of its industry peers.
The Debt to FCF ratio of NRC is 3.27, which is a good value as it means it would take NRC, 3.27 years of fcf income to pay off all of its debts.
NRC has a Debt to FCF ratio of 3.27. This is in the better half of the industry: NRC outperforms 77.45% of its industry peers.
A Debt/Equity ratio of 1.85 is on the high side and indicates that NRC has dependencies on debt financing.
NRC has a Debt to Equity ratio of 1.85. This is in the lower half of the industry: NRC underperforms 75.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.85
Debt/FCF 3.27
Altman-Z 3.1
ROIC/WACC3.5
WACC8.08%
NRC Yearly LT Debt VS Equity VS FCFNRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 0.55 indicates that NRC may have some problems paying its short term obligations.
NRC's Current ratio of 0.55 is on the low side compared to the rest of the industry. NRC is outperformed by 90.20% of its industry peers.
A Quick Ratio of 0.55 indicates that NRC may have some problems paying its short term obligations.
The Quick ratio of NRC (0.55) is worse than 85.29% of its industry peers.
Industry RankSector Rank
Current Ratio 0.55
Quick Ratio 0.55
NRC Yearly Current Assets VS Current LiabilitesNRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

1

3. Growth

3.1 Past

The earnings per share for NRC have decreased strongly by -16.54% in the last year.
The Earnings Per Share has been decreasing by -3.70% on average over the past years.
NRC shows a decrease in Revenue. In the last year, the revenue decreased by -3.72%.
The Revenue has been growing slightly by 2.25% on average over the past years.
EPS 1Y (TTM)-16.54%
EPS 3Y-10.59%
EPS 5Y-3.7%
EPS Q2Q%-22.18%
Revenue 1Y (TTM)-3.72%
Revenue growth 3Y-1.13%
Revenue growth 5Y2.25%
Sales Q2Q%-2.88%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NRC Yearly Revenue VS EstimatesNRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NRC Yearly EPS VS EstimatesNRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2023 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.41 indicates a reasonable valuation of NRC.
Based on the Price/Earnings ratio, NRC is valued cheaper than 87.25% of the companies in the same industry.
NRC's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.87.
Industry RankSector Rank
PE 11.41
Fwd PE N/A
NRC Price Earnings VS Forward Price EarningsNRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

80.39% of the companies in the same industry are more expensive than NRC, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NRC indicates a rather cheap valuation: NRC is cheaper than 81.37% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 14.11
EV/EBITDA 7.33
NRC Per share dataNRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

NRC has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.49%, NRC is a good candidate for dividend investing.
The stock price of NRC dropped by -28.79% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
NRC's Dividend Yield is rather good when compared to the industry average which is at 2.58. NRC pays more dividend than 98.04% of the companies in the same industry.
NRC's Dividend Yield is rather good when compared to the S&P500 average which is at 2.46.
Industry RankSector Rank
Dividend Yield 4.49%

5.2 History

The dividend of NRC decreases each year by -17.40%.
NRC has paid a dividend for at least 10 years, which is a reliable track record.
NRC has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-17.4%
Div Incr Years3
Div Non Decr Years3
NRC Yearly Dividends per shareNRC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

NRC pays out 46.22% of its income as dividend. This is a bit on the high side, but may be sustainable.
NRC's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP46.22%
EPS Next 2YN/A
EPS Next 3YN/A
NRC Yearly Income VS Free CF VS DividendNRC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
NRC Dividend Payout.NRC Dividend Payout, showing the Payout Ratio.NRC Dividend Payout.PayoutRetained Earnings

NATIONAL RESEARCH CORP

NASDAQ:NRC (4/29/2025, 4:05:08 PM)

After market: 11.87 0 (0%)

11.87

+1.03 (+9.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-05 2024-11-05/amc
Earnings (Next)05-06 2025-05-06
Inst Owners52.14%
Inst Owner Change0.28%
Ins Owners0.69%
Ins Owner Change3.36%
Market Cap270.52M
Analysts45
Price TargetN/A
Short Float %2.78%
Short Ratio3.67
Dividend
Industry RankSector Rank
Dividend Yield 4.49%
Yearly Dividend0.48
Dividend Growth(5Y)-17.4%
DP46.22%
Div Incr Years3
Div Non Decr Years3
Ex-Date03-28 2025-03-28 (0.12)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.41
Fwd PE N/A
P/S 1.89
P/FCF 14.11
P/OCF 7.81
P/B 8.65
P/tB N/A
EV/EBITDA 7.33
EPS(TTM)1.04
EY8.76%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.84
FCFY7.09%
OCF(TTM)1.52
OCFY12.8%
SpS6.28
BVpS1.37
TBVpS-1.64
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 18.7%
ROE 79.21%
ROCE 36.9%
ROIC 28.29%
ROICexc 29.58%
ROICexgc 115.49%
OM 24.94%
PM (TTM) 17.32%
GM 60.2%
FCFM 13.41%
ROA(3y)22.78%
ROA(5y)24%
ROE(3y)62.21%
ROE(5y)57.67%
ROIC(3y)37.15%
ROIC(5y)35.26%
ROICexc(3y)44.09%
ROICexc(5y)48.46%
ROICexgc(3y)273.96%
ROICexgc(5y)N/A
ROCE(3y)48.46%
ROCE(5y)46%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-21.97%
ROICexc growth 5Y-12.09%
OM growth 3Y-10.18%
OM growth 5Y-5.95%
PM growth 3Y-11.83%
PM growth 5Y-7.25%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
F-Score4
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 1.85
Debt/FCF 3.27
Debt/EBITDA 1.39
Cap/Depr 256.53%
Cap/Sales 10.8%
Interest Coverage 14.62
Cash Conversion 83.04%
Profit Quality 77.39%
Current Ratio 0.55
Quick Ratio 0.55
Altman-Z 3.1
F-Score4
WACC8.08%
ROIC/WACC3.5
Cap/Depr(3y)236.79%
Cap/Depr(5y)169.97%
Cap/Sales(3y)9.3%
Cap/Sales(5y)6.92%
Profit Quality(3y)77.54%
Profit Quality(5y)88.07%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.54%
EPS 3Y-10.59%
EPS 5Y-3.7%
EPS Q2Q%-22.18%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.72%
Revenue growth 3Y-1.13%
Revenue growth 5Y2.25%
Sales Q2Q%-2.88%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.05%
EBIT growth 3Y-11.19%
EBIT growth 5Y-3.83%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14.14%
FCF growth 3Y-22.27%
FCF growth 5Y-11.96%
OCF growth 1Y-9.15%
OCF growth 3Y-9.26%
OCF growth 5Y-3.29%